Govt likely to float global tender for HPV vax in April

The Health Ministry intends to roll out HPV vaccine against cervical cancer in the national immunisation program for girls aged 9 to 14 years in June for which a global tender is likely to be floated in April, official sources have said.

Serum Institute’s made-in-India HPV vaccine “CERVAVAC” was launched by Union Home Minister Amit Shah on January 24, in presence of the Pune-based firm’s CEO Adar Poonawalla and Prakash Kumar Singh, its Director-Government and Regulatory Affairs. “The ministry is likely to float in April a global tender for 16.02 crore doses of HPV vaccine, which will be supplied by 2026. Apart from domestic manufacturer Serum Institute of India, global vaccine manufacturer Merck is also likely to participate in the tender,” an official source said.

In July last year, India’s drug regulator granted market authorization to Serum Institute of India’s indigenously developed HPV vaccine. It has also been cleared by government advisory panel National Technical Advisory Group on Immunisation (NTAGI) for use in the public health program. PTI